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1576Objective: Depolarizing potassium cardioplegia does not afford optimal cardioprotection in pediatric or adult
patients requiring complicated operative procedures. Polarizing adenosine–lidocaine cardioplegia has been
shown to be cardioprotective without hyperkalemia. Our aim was to examine the effects of changing extracellular
potassium levels in adenosine–lidocaine cardioplegia on arrest and reanimation properties.
Methods: Isolated–perfused rat hearts (n ¼ 96) were arrested at 32C to 33C for 1 or 2 hours with intermittent
200 mmol/L adenosine and 500 mmol/L lidocaine in modified Krebs–Henseleit buffer with 0.1, 3.0, 5.9, 10, and
16 mmol/L potassium or with 16 or 25 mmol/L potassium in Krebs–Henseleit buffer (n ¼ 8 for each group).
Membrane potentials were estimated in the arrested ventricular myocardium (n ¼ 42), and recovery function
was measured in working mode during 60 minutes’ reperfusion.
Results: Arrest was interrupted by breakout beats in the adenosine–lidocaine hypokalemic (0.1 and 3 mmol/L
potassium) and non–adenosine–lidocaine hyperkalemic (16 and 25 mmol/L potassium) groups. The membrane
potentials for the non–adenosine–lidocaine 16 and 25 mmol/L potassium groups were51 and39 mV, and those
for the adenosine–lidocaine groups (0.1, 3.0, 5.9, 10, and 16 mmol/L potassium) were183,94,75,65, and
49 mV, respectively. After 1 hour of arrest, coronary vascular resistance increased linearly in adenosine–lido-
caine cardioplegia with increasing potassium levels (5.9, 10, and 16 mmol/L), and the slope increased more
than 2-fold after 2 hours. Nearly 40% of hearts in the adenosine–lidocaine (0.1 mmol/L potassium) and non–
adenosine–lidocaine 25 mmol/L potassium groups failed to recover after 1 hour arrest. After 2 hours, hearts in
the polarizing (5.9 mmol/L potassium) adenosine–lidocaine group increased coronary vascular resistance by
only 30% and spontaneously recovered 107% heart rate, 92% systolic pressure, 81% aortic flow, and 113%
coronary flow (all metrics returned 85% to 100% at 15 minutes) with no reperfusion arrhythmias. In contrast,
hearts in the adenosine–lidocaine (3, 10, and 16 mmol/L potassium) groups were all slow to recover (15% to
40% return at 15 minutes) and experienced arrhythmias. Increasing potassium levels in adenosine–lidocaine
cardioplegia from 5.9 to 16 mmol/L resulted in a 67% loss of left ventricular contractility.
Conclusions: Polarizing adenosine–lidocaine cardioplegia (5.9 mmol/L potassium) administered intermittently
at 33C provides superior arrest and reanimation profiles under normokalemic conditions when the myocardial
cell membrane potential is close to its resting state. (J Thorac Cardiovasc Surg 2010;139:1576-86)Cardiac surgeons are currently facing unprecedented chal-
lenges and pressures from health care providers, surgeon
shortages, and a sicker, older patient cohort with more dif-
fuse multivessel disease and a higher incidence of diabetes,
obesity, metabolic disorders, renal disease, failed angio-
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The Journal of Thoracic and Cardiovascular Sursurgery, the older patient presenting with a diseased heart
without complicating comorbidities will be a surgical rarity.
High-potassium cardioplegia has been identified as a major
factor associated with poor outcomes in adult bypass, valvular,
or pediatric congenital corrective operations.2,3 For more than
40 years, surgeons and scientists have sought alternatives to
high-potassium cardioplegia, which arrests the heart at depo-
larized membrane potentials (50 to60 mV).4-8 Potassium
(Kþ)-induced depolarization and the resulting intracellular
Naþand Ca2þ loading can lead to myocardial and microvascu-
lar injury,9 coronary vasoconstriction and spasm,9 arrhyth-
mias,10 and right and left ventricular stunning11 and
potentiate the local inflammatory response with free radical
production.5,11 Apart from electrochemical arrest, hyperkale-
mic cardioplegia offers the patient little or no cardioprotection.
For more than 10 years, our laboratory has developed
a normokalemic nondepolarizing cardioplegia to place the
heart in a more natural state of suspended animation andgery c June 2010
Abbreviations and Acronyms
AF ¼ aortic flow
AL ¼ adenosine–lidocaine
CF ¼ coronary flow
CO ¼ cardiac output
CVR ¼ coronary vascular resistance
HR ¼ heart rate
Kþ ¼ potassium
K–H ¼ Krebs–Henseleit
SV ¼ stroke volume
Sloots and Dobson Evolving Technology/Basic Science
E
T
/B
Sarousal akin to natural hibernation.6 Adenosine and lido-
caine, the active components of adenosine–lidocaine (AL)
cardioplegia, clamp the membrane potential close to its rest-
ing voltage of83 mV, reduce coronary vascular resistance
(CVR), and improve functional recovery.12 AL cardioplegia
can arrest the heart for up to 4 hours at 29C with small in-
creases in CVR, 85% to 100% recovery of heart rate (HR)
and systolic pressure, and 70% to 80% recovery of cardiac
output (CO), whereas only 17% of hearts arrested with hy-
perkalemic St Thomas Hospital solution no. 2 (Plegisol;
Hospira, Inc, Lake Forest, Ill) survived.12 Further proof of
concept was demonstrated by using AL all-blood cardiople-
gia in the canine model of cardiopulmonary bypass.13 More
recently, we have shown that AL cardioplegia can be deliv-
ered continuously or intermittently at 33C with no signifi-
cant loss in functional parameters,7 and we are currently
developing the concept for heart transplantation.8 At nonarr-
est concentrations, AL intravenous infusions during regional
ischemia have also been shown to reduce mortality, arrhyth-
mias, and infarct size14; however, there is much controversy
about whether a lidocaine bolus administered during ische-
mia followed by adenosine at reperfusion has similar cardi-
oprotective effects (Canyon and Dobson, unpublished
data).15-17
The aim of the present study was to examine the effect of
varying levels of extracellular Kþ in AL cardioplegia (0.1,
3.0, 5.9, 10, and 16 mmol/L Kþ) on diastolic membrane po-
tential, CVR, incidence of arrhythmias, time to first beat,
HR, systolic pressures, aortic and coronary flows (CFs),
CO, and stroke volume (SV) after 1 and 2 hours of arrest
at 32C to 33C. We report that polarized AL cardioplegia
(5.9 mmol/L Kþ) provides superior arrest and recovery pro-
files and might offer an alternative to hyperkalemic solutions
in pediatric and adult cardiac surgery.
MATERIALS AND METHODS
Animals
Male Sprague–Dawley rats (390–450 g) were fed ad libitum and housed
in a 14/10-hour light/dark cycle. Rats were anesthetized with an intraperito-
neal injection of thiopentone sodium (100 mg/kg body weight) and handled
in compliance with James Cook University Ethics approval number A1107The Journal of Thoracic and Carand with the ‘‘Guide for care and use of laboratory animals’’ from the Na-
tional Institutes of Health (publication no. 85-23, Public Health Service pub-
lication 1996). Adenosine and other chemicals were obtained from Sigma
Chemical Co (Castle Hill, New South Wales, Australia). Lidocaine hydro-
chloride was purchased as a 2% solution (ilium) from Lyppard (Queens-
land, Australia).
Composition of Buffers and Arrest Solutions
Krebs–Henseleit perfusion buffer. Hearts were perfused in the
Langendorff and working mode with a modified Krebs–Henseleit (K–H)
buffer containing 10 mmol/L glucose (117 mmol/L NaCl, 5.9 mmol/L
KCl, 25 mmol/L NaHCO3, 1.2 mmol/L NaH2PO4, 1.12 mmol/L CaCl2
[free Ca2þ ¼ 1.07 mmol/L], and 0.512 mmol/L MgCl2 [free Mg2þ ¼ 0.5
mmol/L], pH 7.4) and bubbled with 95% O2/5% CO2 at 37
C.7,12
AL arrest solutions. Adenosine (200 mmol/L) and lidocaine (500
mmol/L) were added to K–H buffer containing either 0.1, 3, 5.9, 10, or 16
mmol/L Kþwith 10 mmol/L glucose, pH 7.7.7,12
Hyperkalemic arrest solutions. Kþ, 16 and 25 mmol/L, was
added to K–H buffer containing 10 mmol/L glucose, filtered, and main-
tained at 37C. The total Kþ concentration in these solutions was 16 and
25 mmol/L (as KCl). Arrest solutions were filtered with a 0.2-mm filter
and not bubbled.
Experimental Protocols and Groups
Rats were randomly assigned to one of 3 experiments and 20 groups.
Cardiac membrane potential. There were 8 groups (n ¼ 6 for
each group), control (nonarrest) and immediately after arrest (at induction):
AL 0.1, 3, 5.9, 10, and 16 mmol/L Kþ and 16 and 25 mmol/L Kþ alone.
One-hour arrest. There were 7 groups (n ¼ 8 for each group): AL
0.1, 3, 5.9, 10, and 16 mmol/L Kþ and 16 and 25 mmol/L Kþ alone.
Two-hour arrest. There were 5 groups (n ¼ 8 for each group): AL 3,
5.9, 10, and 16 mmol/L Kþ and 16 mmol/L Kþ alone. Note that we did not
include AL 0.1 mmol/L Kþor 25 mmol/L Kþalone groups because 40% of
them failed to recover after 1 hour’s arrest.
Langendorff and Working Rat Heart Preparation
Hearts were placed in ice-cold K–H buffer, cleaned, and then connected
through the aorta to a standard Langendorff apparatus and perfused in a retro-
grade fashion at 80 cm H2O (60 mm Hg).
12 The pulmonary artery and left
atrium were cannulated, and the heart was switched to working mode. The
preload was 10 cm H2O, and the afterload was 100 cm H2O (76 mm Hg). After
10 minutes of stabilization, hearts were switched to nonworking mode to ad-
minister the arrest solution. HR, aortic pressure, CF, and aortic flow (AF) were
measured before, during, and after arrest, as reported previously.7,12 After ar-
rest, hearts were switched to working mode, and function was monitored, as
described previously.7,12 No pacing or cardiac massage was used. The heart’s
temperature was measured with a Cole–Palmer temperature sensor (8402-20;
Cole–Parmer, Vernon Hills, Ill) tucked under the left auricle.7 Breakout beats
were monitored visually, timed, and recorded during induction of arrest and
during and between maintenance cardioplegic flushes. Heart rhythm was not
assessed with an electrocardiogram, but irregularities in rhythm were noted,
together with their effect on HR, developed pressures, and CO.
Arrest Induction Protocol
Fifty milliliters of cardioplegia was administered at 60 mm Hg, and the
aorta was crossclamped for 18 minutes, after which a 2-minute infusion
pulse of cardioplegia was administered and the clamp was reapplied. Cardi-
oplegic volumes were measured for estimating CVR.7 The arrest tempera-
ture of 32C to 33C was chosen from the studies that reported that tepid
temperatures provided optimal heart recovery and brain protection during
cardiac surgery.7 Estimation of myocardial membrane potential and CVR
can be found in Appendix 1.diovascular Surgery c Volume 139, Number 6 1577
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All results are expressed as means  standard errors of the mean. Data
from the 1- and 2-hour protocols were analyzed separately. One-way anal-
ysis of variance was used to compare data at specific time points (eg, arrest
time and time to first reperfusion beat; Tables 1 and 2 and Figures 1, B; 2, A
and B; and 3, A). Two-way analysis of variance with repeated measures was
used to compare functional parameters of the different cardioplegia groups
across multiple time points during the arrest period and 60 minutes of reper-
fusion (Figures 1, B, and 3, A and B). Significance was assessed with Tukey
and Dunnett (2-sided) post-hoc tests. The alpha level of significance for all
experiments was set at P< .05.RESULTS
Arrest Times and Membrane Potentials
Times to arrest for the AL cardioplegia groups were not
significantly different and ranged from 7.4  0.6 to 11 
1.3 seconds. Arrest times were significantly increased in
hearts perfused with 16 mmol/L Kþ alone (22  2 to 28 
8 seconds) and decreased in the presence of 25 mmol/L Kþ
alone (13.4  1.1 seconds). Nearly all hearts perfused
with hypokalemic AL solutions (0.1 and 3 mmol/L Kþ)
failed to maintain arrest; breakout beats occurred for 9.8 
1.3 minutes and 7.1  0.6 minutes, respectively. Similarly,
hearts perfused with 16 mmol/L Kþ alone and 25 mmol/L
Kþ alone had breakout beats lasting for 2.5 to 25 minutes
and for 8 seconds to 11 minutes, respectively, after which ar-
rest occurred. The membrane potential for each group is
found in Figure 1, A, and Table 1. The prearrest value wasTABLE 1. Arrest parameters: 1- and 2-hour warm arrest protocols (32C
1-h Arrest
Cor
vascular
(megadyne
Arrest solution
Diastolic
membrane
potential (n ¼ 6)
Cardioplegic
flush volume
(mL)* End induction
AL (0.1 mmol/L Kþ) 183  1 mV 74  2 0.25  0
AL (3.0 mmol/L Kþ) 94  1 mV 87  3 0.26  0.01
AL (5.9 mmol/L Kþ) 75  2 mV 104  1y 0.24  0.01
AL (10 mmol/L Kþ) 65  1 mV 109  3z 0.24  0.01
AL (16 mmol/L Kþ) 49  1 mV 89  3 0.26  0.01
16 mmol/L Kþ 51  1 mV 71  2 0.35  0.02k
25 mmol/L Kþ 39  1 mV 56  2x 0.38  0.02{
The diastolic membrane potential of the left ventricle was calculated from the Nernstian di
lidocaine;ND, not determined), AL 0.1 mmol/L potassium (Kþ) or 25 mmol/L Kþalone were n
*Volume of cardioplegic solution administered during 2-minute flushes during the mainten
yP< .01 compared with AL 0.1 mmol/L Kþ and 16 mmol/L Kþ groups.
zP< .01 compared with AL 0.1 mmol/L Kþ and 16 mmol/L Kþ groups, P< .05 compared
xP< .01 compared with AL 3, 5.9, 10, and 16 mmol/L Kþ and 16 mmol/L Kþ groups, P<
kP< .01 compared with all groups except 25 mmol/L Kþ.
{P< .01 compared with all groups except 16 mmol/L Kþ.
#P< .05 compared with AL 5.9 and 10 mmol/L Kþ and 25 mmol/L Kþ groups.
**P< .01 compared with AL 5.9 and 10 mmol/L Kþ groups.
yyP< .05 compared with all other groups.
zzP< .05 compared with AL 3 mmol/L Kþ and 16 mmol/L Kþ groups.
xxP< .01 compared with all other groups.
kkP< .01 compared with AL 3 and 16 mmol/L Kþ and 16 mmol/L Kþ groups.
1578 The Journal of Thoracic and Cardiovascular Sur78  1 mV at 37C. Total tissue water content was not sig-
nificantly different among the groups (86.0  0.4% to 87.1
 0.5%, n ¼ 6 each).CVR During Induction and 2-Minute ‘‘Flushes’’
During induction, there were no significant differences in
the rate of coronary outflow in the AL groups, although
a 5% increase occurred in the AL 5.9 mmol/L Kþ group.
In contrast, the rates in the 16 mmol/L and 25 mmol/L Kþ
alone groups were significantly decreased (24% and 35%
decrease, respectively; Table 1). The significant increase in
CVR for the 16 mmol/L Kþ group is also shown on the
y-axis of Figure 1, B (‘‘end of induction’’).
Maintenance cardioplegic volumes and CVR measured
during 2-minute flushes every 18 minutes over 1 and 2
hours’ arrest are shown in Table 1 and Figure 1, B. Signif-
icantly greater volumes were delivered to the AL 5.9
mmol/L Kþ and AL 10 mmol/L Kþ groups. After 1 hour’s
arrest, the AL 0.1 mmol/L Kþ and 25 mmol/L Kþ alone
groups had the highest CVRs. Nearly 40% (3/8) of hearts
in each of these 2 groups subsequently failed to recover
aortic/coronary flows after 1 hour’s arrest, and therefore
we did not include them in the longer arrest study. After
2 hours’ arrest, the AL 5.9 mmol/L Kþ group had the low-
est CVR (Figure 1, B). As the membrane potential devi-
ated from near-resting voltage (ie, from AL 5.9 mmol/L–33C)
2-h Arrest
onary
resistance
$ s1 $ cm5)
Coronary
vascular resistance
(megadyne $ s1 $ cm5)
At 58 min arrest
Cardioplegic
flush volume
(mL)* End induction At 118 min arrest
0.53  .02# ND ND ND
0.40  0.03 138  5 0.25  0.01 0.65  0.06
0.29  0.01 203  3zz 0.24  0.01 0.31  0.01kk
0.28  0.02 155  4 0.27  0.01 0.47  0.03
0.40  0.06 157  6 0.28  0.01 0.57  0.07
0.46  0.03** 139  5 0.40  0.03xx 0.57  0.05
0.61  0.05yy ND ND ND
stribution of potassium ions (see the Materials and Methods section). AL, Adenosine–
ot determined because approximately 40% failed to recover function after 1 hour arrest.
ance period.
with AL 3 and 16 mmol/L Kþ groups.
.05 compared with the AL 0.1 mmol/L Kþ group.
gery c June 2010
TABLE 2. Functional parameters of isolated rat hearts before arrest and at 60 minutes’ reperfusion (working mode) after 1 or 2 hours’ arrest at
32C to 33C
Heart rate
Systolic
pressure
Diastolic
pressure Aortic flow Coronary flow
Cardiac
output Stroke volume
Treatment groups
(n ¼ 8 each group) beats/min % PA mm Hg % PA mm Hg % PA mL/min % PA mL/min % PA mL/min % PA mL/beat % PA
AL (0.1 mmol/L Kþ)
Before arrest 338  6 61 133  2 54 75  3 66 56  2 28 22  1 41 78  2 32 0.23  0.1 32
1-h Arrest 206  61 71  21 51  15 16  6{ 9  3y 25  9 0.07  0.02
AL (3 mmol/L Kþ)
Before arrest 336  15 99 129  4 92 71  3 105 57  2 81 20  1 90 77  2 83 0.23  0.1 84
1-h Arrest 329  7 118  3 74  2 46  2 18  1 64  3 0.19  0.01
Before arrest 304  10 45 131  3 23 61  1 32 60  2 11 20  1 17 79  3 13 0.26  0.1 13
2-h arrest 133  43* 32  18* 20  10* 6  5k 4  2k 10  7k 0.04  0.02k;
AL (5.9 mmol/L Kþ)
Before arrest 301  19 110 131  4 94 73  2 100 56  2 91 19  1 101 75  3 93 0.25  0.1 86
1-h Arrest 327  16 124  4 73  2 51  3 19  1 70  3 0.22  0.01
Before arrest 291  11 107 130  1 92 61  1 100 59  2 81 18  1 113 77  2 89 0.26  0.1 84
2-h Arrest 309  9 120  2 61  1 48  2# 21  1# 69  2# 0.22  0.01#
AL (10 mmol/L Kþ)
Before arrest 320  10 102 132  2 94 71  2 110 60  1 79 20  1 97 79  1 84 0.25  0.1 83
1-h arrest 325  9 124  2 78  3 47  1 19  1 66  2 0.21  0.01
Before arrest 338  15 95 124  1 92 60  1 107 56  1 71 19  1 81 75  2 74 0.23  0.1 80
2-h arrest 317  16 114  2 64  1 40  2 16  1 56  1 0.18  0.01
AL (16 mmol/L Kþ)
Before arrest 309  15 103 131  2 93 71  2 101 56  1 81 19  1 94 75  1 84 0.25  0.1 82
1-h arrest 318  15 122  3 72  3 45  2 18  2 18  2 0.20  0.01
Before arrest 309  14 64 139  2 53 61  1 65 57  2 29 19  1 33 76  2 36 0.25  0.1 39
2-h Arrest 208  33 74  23 39  11 20  8 8  3 28  11 0.10  0.04
16 mmol/L Kþ alone
Before arrest 329  6 133  2 73  3 59  1 19  1 78  2 0.24  0.1
1-h arrest 306  25 94 117  3 88 78  3 107 40  5 69 15  1 81 55  5 72 0.18  0.01 76
Before arrest 304  9 134  3 61  1 56  1 18  1 75  2 0.25  0.1
2-h arrest 248  47 76 74  21 56 41  12 65 25  8 40 10  3 49 35  10 46 0.11  0.03 43
25 mmol/L Kþ alone
Before arrest 306  12 136  3 66  3 59  1 20  1 79  1 0.26  0.1
1-h arrest 189  56y 63 78  23z 57 44  13x 66 26  8y 43 11  3y 54 37  11** 46 0.12  0.04y 46
%PA, Percentage of prearrest value; AL, adenosine–lidocaine.
*P< .01 compared with AL 5.9 and 10 mmol/L potassium (Kþ) groups.
yP< .05 compared with AL 3, 5.9, 10, and 16 mmol/L Kþ groups.
zP< .05 compared with AL 5.9 and 10 mmol/L Kþ groups.
xP< .05 compared with AL 3 and 10 mmol/L Kþ and 16 mmol/L Kþ alone groups.
kP< .01 compared with the AL 10 mmol/L Kþ group.
{P< .01 compared with all groups except the 25 mmol/L Kþ alone group.
#P< .01 compared with the AL 3 and 16 mmol/L Kþ and 16 mmol/L Kþ alone groups.
**P< .01 compared with the AL 3, 5.9, 10, and 16 mmol/L Kþ groups.
Sloots and Dobson Evolving Technology/Basic Science
E
T
/B
SKþ), the CVR increased, and this effect was magnified as
arrest time increased (Figure 1, C).
Time to First Spontaneous Beat and Aortic Flow
After 1 hour’s arrest, times to first beat increased from
0.9 minutes (AL 0.1 mmol/L Kþ) to 5.2 minutes (25
mmol/L Kþ alone; Figure 2, A). The effect of doubling
crossclamp time led to longer times to first beat, with
the exception of the AL 5.9 mmol/L Kþ and AL 3.0
mmol/L Kþ groups (Figure 2, A). Time to first AF in-The Journal of Thoracic and Carcreased from 3.1 minutes (16 mmol/L Kþ alone) to 13.9
minutes (AL 16 mmol/L Kþ; Figure 2, B). Doubling arrest
time resulted in up to 2.4 longer times to generate AF (Fig-
ure 2, B). Nineteen hearts failed to achieve AF in our
study: AL 0.1 mmol/L Kþ (3 hearts after 1 hour’s arrest),
AL 3 mmol/L Kþ (6 hearts after 2 hours’ arrest), AL 16
mmol/L Kþ (4 hearts after 2 hours’ arrest), 16 mmol/L
Kþ alone (3 hearts after 2 hours’ arrest), and 25 mmol/L
Kþ alone (3 hearts after 1 hour’s arrest). AL 5.9 mmol/L
Kþ and AL 10 mmol/L Kþwere the only 2 groups in whichdiovascular Surgery c Volume 139, Number 6 1579
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FIGURE 1. A, The effect of increasing potassium (Kþ) concentrations on
the left ventricular diastolic membrane potential in the isolated Langendorff
rat heart arrested with adenosine–lidocaine (AL) cardioplegia (3.0, 5.9, 10,
and 16 mmol/L Kþ) or 16 mmol/L Kþ alone and 25 mmol/L Kþ alone in
Krebs–Henseleit buffer. Membrane potentials (4) were calculated from
the Nerstian distributions of Kþ (see the Materials and Methods section
for details). The relationship between diastolic membrane potential and ex-
tracellular Kþ is as follows: 4 (mV) ¼ 26.23 ln [Kþ]123.44 (R2 ¼ 0.99),
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Sall hearts recovered AF after 1 and 2 hours’ arrest at 33C.
The effect of membrane potential and increasing Kþ con-
centrations in AL cardioplegia on time to first beat and
AF are shown in Figures 2, C and D.
Early Reperfusion Ventricular Arrhythmias
During reanimation and before AF was achieved, abnor-
mal rhythms were observed in hearts from the AL 0.1
mmol/L Kþ (2 hearts), 16 mmol/L Kþ alone (1 heart), and
25 mmol/L Kþ alone (2 hearts) groups arrested for 1 hour,
and after 2 hours in the AL 10 mmol/L Kþ (3 hearts), AL
16 mmol/L Kþ(4 hearts), and 16 mmol/L Kþalone (2 hearts)
groups.
Functional Recovery
Recovery of HR, systolic and diastolic pressures, aortic and
coronary flows, CO, and SV for the 1- and 2-hour arrest
groups are shown in Table 2 and Figure 3. During prearrest,
there were no significant differences between the groups. Af-
ter 1 and 2 hours’ arrest, the AL 5.9 mmol/L Kþgroup recov-
ered 107% to 110% of its prearrest HR at 60 minutes’
reperfusion (94% to 98% of recovery occurred at 15 min-
utes), which was significantly higher than that seen in the
AL 3, 10, and 16 mmol/L Kþgroups after 2 hours’ arrest. Af-
ter 1 hour’s arrest, the AL 10, 16, and 3 mmol/L Kþ and 16
mmol/L Kþ alone groups recovered 84%, 70%, 79%, and
99% of their prearrest HR at 15 minutes’ and 102%,
103%, 99%, and 94% at 60 minutes’ reperfusion, respec-
tively. After 2 hours’ arrest, the AL 10 mmol/L Kþgroup re-
covered 95% at 60 minutes; however, only 36% recovery
occurred at 15 minutes. The 16 mmol/L Kþ alone, AL 16
mmol/L Kþ, and AL 3 mmol/L Kþ groups recovered 79%,
28%, and 39% of their respective pre-arrest HRs at 15 min-
utes’ and 76%, 64%, and 45% at 60 minutes’ reperfusion
(Table 2). The relationship between HR and increasing extra-
cellular Kþ concentrations in AL cardioplegia at 15 minutes’
reperfusion after 1 hour’s arrest was as follows: HRwhere [Kþ] is the extracellular Kþ concentration in millimoles per liter. B,
The effect of arrest time on coronary vascular resistance (CVR) during inter-
mittent cardioplegic flushes (2minutes every 18minutes) over a 2-hour arrest
period (1-hour arrest groups are not shown). N, 16 mmol/L Kþ alone,
P< .01 (1-way analysis of variance) compared with AL 3.0, 5.9, 10, and
16 mmol/L Kþ.þþ, AL 3.0 mmol/L Kþ, P<.05 (1-way analysis of variance)
compared with AL 10 mmol/L Kþ. *, AL 5.9 mmol/L Kþ, P< .05 (by re-
peated measures) compared with AL 3 and 16 mmol/L Kþ and 16 mmol/
L Kþalone. C, The effect of variation in the membrane potential on coronary
vascular resistance (CVR) for groups arrested for 1 and 2hours at 32C to
33C. The AL 0.1 mmol/L Kþ group (4 ¼183 mV) and the 25 mmol/L
Kþalone group (4¼39 mV) were not included in the 2-hour arrest groups
because nearly 40% failed to return aortic flow after 1hour arrest. Insert,
Comparison of CVR after 1 or 2 hours’ arrest with AL containing 5.9,
10, or 16 mmol/L Kþ. CVR after 1 hour’s arrest was as follows: CVR ¼
0.0116 [Kþmmol/L] þ0.2004 (R2¼ 0.78). That after 2hours was as follows:
CVR ¼ 0.0251 [Kþ]þ0.1834, R2 ¼ 0.94.
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FIGURE 2. A, Time to first ventricular beat at reanimation in working
mode after 1 hour’s (shaded) or 2 hours’ (not shaded) arrest. Adenosine–
lidocaine (AL) 0.1mmol/L potassium (Kþ) and 25 mmol/L Kþ alone were
not included in the 2-hour arrest study because approximately 40% failed
to recover function after 1 hour’s arrest (same for panel B). N, AL 0.1
mmol/L Kþ, P< .05 compared with AL 10 and 16 mmol/L Kþ. d, AL 16
mmol/L Kþ, P< .05 compared with AL 3 and 5.9 mmol/L Kþ and 16
mmol/L Kþ alone. *, AL 16 mmol/L Kþ, P< .01 compared with all other
groups.þþ, 25 mmol/L Kþ alone, P< .05 compared with AL 0.1 and 5.9
Sloots and Dobson Evolving Technology/Basic Science
The Journal of Thoracic and Car(percentage recovery) ¼3.8406 [Kþ mmol/L]þ128.84 (R2
¼ 0.92). That after 2 hours’ arrest was as follows: HR (per-
centage recovery) ¼6.1517 [Kþ mmol/L]þ 118.08 (R2 ¼
0.75).
After 1 and 2 hours’ arrest, hearts in the AL 5.9 mmol/L
Kþ group demonstrated a rapid return of systolic and dia-
stolic pressures, with nearly 100% return at 15 minutes
and 92% to 100% recoveries at 60 minutes (Table 2). After
1 hour’s arrest, the AL 10 mmol/L Kþ and 16 mmol/L Kþ
alone groups recovered 90% to 100% developed pressures
at 15 minutes; however, in contrast to the AL 5.9 mmol/L Kþ
group, the AL 10 mmol/L Kþgroup was slow to recover after
2 hours’ arrest, with only 50% developed pressures at 15
minutes. After 2 hours, the AL 16 mmol/L Kþ and 16
mmol/L Kþalone groups recovered 43% to 66% developed
pressures at 15 minutes, and the AL 3 mmol/L Kþgroup re-
covered only 17% to 26% at 15 minutes; developed pres-
sures for these groups changed little over the next 45
minutes (Table 2).
After 1 and 2 hours’ arrest, the AL 5.9 mmol/L Kþgroup
recovered 81% to 91% of its prearrest AF at 60 minutes
(Table 2), and nearly 100% return occurred at 15 minutes.
After 2 hours’ arrest, this recovery for the AL 5.9 mmol/L
Kþ group was significantly higher than for all other groups
(Table 2). After 1 hour’s arrest, the AL 10, 16, and 3
mmol/L Kþ and 16 mmol/L Kþ alone groups recovered
57%, 44%, 71%, and 75%, respectively, of prearrest AF
at 15 minutes and 79%, 81%, 81%, and 69% at 60 minutes
(Table 2). Hearts in the 25 mmol/L Kþalone group recovered
significantly less, with 43%AF at 60 minutes (49% return at
15 minutes). Hearts in the AL 0.1 mmol/L Kþ group recov-
ered 28% (15% at 15 minutes). After 2 hours’ arrest, the
AL 10 mmol/L Kþ group recovered 71% at 60 minutes but
showed only 26% return at 15 minutes. The 16 mmol/L Kþ
alone, AL 16 mmol/L Kþ, and AL 3 mmol/L Kþgroups recov-
ered 33%, 15%, and 4%, respectively, of their prearrest AF
at 15 minutes (Table 2). The relationship between AF and in-
creasing extracellular Kþ concentrations in AL cardioplegiammol/L Kþ and 16 mmol/L Kþ alone. B, Time to aortic flow at reperfusion
after 1 hour’s (shaded) or 2 hours’ (not shaded) arrest.N, AL 10 mmol/L
Kþ, P<.01 compared with 16 mmol/L Kþalone. d, AL 16 mmol/L Kþ, P<
.05 compared with AL 3 and 5.9 mmol/L Kþ. *, AL 16 mmol/L Kþ, P<.05
compared with AL 5.9 mmol/L Kþand 16 mmol/L Kþalone.þþ, 16 mmol/L
Kþalone, P<.01 compared with AL 10 and 16 mmol/L Kþ. C, Relationship
between the time to first beat at reanimation after 1 or 2 hours’ arrest and the
concentration of Kþ in AL cardioplegic solution (5.9, 10, and 16 mmol/L
Kþ). Time to first beat after 1hour was as follows: Time to first beat (min)
¼ 0.3131 [Kþ] þ 0.5703, (R2 ¼ 0.99). That after 2hours was as follows:
Time to first beat (min) ¼ 0.9474 [Kþ]3.3076 (R2¼ 0.99). D, Relationship
between the time to aortic flow after 1 or 2 hours’ arrest and the concentra-
tion of Kþ in AL cardioplegic solution (5.9, 10, and 16 mmol/L Kþ). Time to
aortic flow after 1hour was as follows: Time to aortic flow (min) ¼ 0.727
[Kþ]þ3.3035 (R2 ¼ 0.84). That after 2hours was as follows: Time to aortic
flow (min) ¼ 1.057 [Kþ]þ3.290 (R2 ¼ 0.88).
diovascular Surgery c Volume 139, Number 6 1581
E
T
/B
S
00.05
0.1
0.15
0.2
0.25
5 30 1 0 45 60
S
t
r
o
k
e
 
V
o
l
u
m
e
 
(
m
l
/
b
e
a
t
)
 
Reperfusion Time (min) 
0.05
0.1
0.15
0.2
0.25
5.9 10 16
S
t
r
o
k
e
 
v
o
l
u
m
e
 
(
m
l
/
b
e
a
t
)
 
a
t
 
6
0
 
m
i
n
 
r
e
p
e
r
f
u
s
i
o
n
 
[K
+
] in AL cardioplegia (mM) 
Polarized  Depolarized 
1 hour arrest
2 hours arrest
0
10
20
30
40
50
60
70
80
90
100
0 15 30 45 60
%
 
C
a
r
d
i
a
c
 
O
u
t
p
u
t
 
++
∗
++
∗
+
AL (5.9 mM K+)
AL (5.9 mM K+)
AL (10 mM K+)
AL (10 mM K+)
AL (16 mM K+)
AL (16 mM K+)
16 mM K+
16 mM K+
AL (3 mM K+)
AL (3 mM K+)
A
B
C
FIGURE 3. A, Recovery of cardiac output (percentage of prearrest values)
during 60 minutes’ reperfusion after 2 hours’ arrest at 32C to 33C.þ, Aden-
osine–lidocaine (AL) 5.9 mmol/L Kþ, P< .01 (1-way analysis of variance)
compared with AL 3, 10, and 16 mmol/L potassium (Kþ) and 16 mmol/L
Kþ alone.þþ, AL 5.9 mmol/L Kþ, P< .01 (1-way analysis of variance) com-
pared with AL 3 mmol/L Kþ, P< .05 (repeated measures) compared with
AL 3 and 16 mmol/L Kþ and 16 mmol/L Kþ alone. *, AL 10 mmol/L Kþ, P
< .01 (repeated measures) compared with AL 3 mmol/L Kþ. B, Recovery of
stroke volume (in milliliters per beat) during 60 minutes’ reperfusion after 2
hours’ arrest at 32C to 33C.þþ, AL 5.9 mmol/L Kþ, P<.01 (repeated mea-
sures) compared with AL 3 and 16 mmol/L Kþand 16 mmol/L Kþalone. *, AL
10 mmol/L Kþ, P<.01 (repeated measures) compared with AL 3 mmol/L Kþ.
C, Relationship between stroke volume and increasing concentrations of Kþin
AL cardioplegic solution (5.9, 10, and 16 mmol/L Kþ) at 60 minutes’ reperfu-
sion for 1- and 2-hour arrest groups. Stroke volume after 1hour was as follows:
Stroke volume¼ 0.0018 [Kþ mmol/L]þ0.2262 (R2¼ 0.65). That after 2hours
was as follows: Stroke volume ¼ 0.012 [Kþ]þ0.294 (R2 ¼ 0.99).
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Sat 15 minutes’ reperfusion after 1 hour’s arrest was as fol-
lows: AF (percentage recovery) ¼4.4704 [Kþ mmol/L]þ
111.53 (R2¼ 0.88). That after 2 hours’ arrest was as follows:1582 The Journal of Thoracic and Cardiovascular SurAF (percentage recovery) ¼6.1885 [Kþmmol/L]þ106.47
(R2 ¼ 0.79).
Recovery of rate and percentage of CF showed profiles
similar to those of AF (Table 2). After 1 and 2 hours’ arrest,
the AL 5.9 mmol/L Kþ group recovered 101% to 113% of
its prearrest CF at 60 minutes, and 95% of this recovery
was achieved at 15 minutes’ reperfusion. After 1 hour’s ar-
rest, the AL 10, 16, and 3 mmol/L Kþ and 16 mmol/L Kþ
alone groups recovered 72%, 65%, 72%, and 78%, respec-
tively, of prearrest CF at 15 minutes and 97%, 94%, 90%,
and 81% at 60 minutes’ reperfusion. Hearts arrested with 25
mmol/L Kþalone recovered only 54% (49% at 15 minutes),
and those arrested with AL 0.1 mmol/L Kþ recovered 41%
(45% at 15 minutes) of their prearrest CF. After 2 hours’ ar-
rest, the AL 10 mmol/L Kþgroup recovered 81% at 60 min-
utes, and only 40% of recovery occurred at 15 minutes. The
16 mmol/L Kþalone, AL 16 mmol/L Kþ, and AL 3.0 mmol/L
Kþgroups recovered 44%, 29%, and 15% of their prearrest
CF at 15 minutes’ and 49%, 33%, and 17% at 60 minutes’
reperfusion, respectively (Table 2). The relationship be-
tween CF and increasing extracellular Kþ concentrations in
AL cardioplegia at 15 minutes’ reperfusion after 1 hour’s ar-
rest was as follows: CF (percentage recovery) ¼2.8375
[Kþmmol/L]þ107.51 (R2¼ 0.84). That after 2 hours’ arrest
was as follows: CF (percentage recovery) ¼6.1885 [Kþ
mmol/L]þ120.47 (R2 ¼ 0.79).
The recovery of CO and SV are shown in Table 2 and Fig-
ure 3. After 1 and 2 hours’ arrest, the AL 5.9 mmol/L Kþ
group recovered 89% to 93% of its prearrest CO at 60 min-
utes (85% to 93% of this recovery at 15 minutes; Figure 3,
A). After 1 hour’s arrest, the AL 10, 16, 3 mmol/L Kþand 16
mmol/L Kþ alone groups recovered 61%, 49%, 71%, and
76% of prearrest CO at 15 minutes’ and 84%, 84%, 83%
and 72% at 60 minutes’ reperfusion, respectively. Hearts ar-
rested with 25 mmol/L Kþalone recovered only 46% (49%
at 15 minutes), and those arrested with AL 0.1 mmol/L Kþre-
covered 32% prearrest CO. The relationship between CO
and increasing extracellular Kþconcentrations in AL cardio-
plegia at 15 minutes’ reperfusion after 1 hour’s arrest was as
follows: CO (percentage recovery) ¼4.1829 [Kþmmol/L]
þ112.15 (R2¼ 0.87). After 2 hours’ arrest, the AL 10 mmol/
L Kþgroup recovered 74% of prearrest value and 27% at 15
minutes’ reperfusion, which was significantly less than that
seen in the AL 5.9 mmol/L Kþ group. The 16 mmol/L Kþ
alone, AL 16 mmol/L Kþ, and AL 3.0 mmol/L Kþgroups re-
covered 40%, 27%, and 7% of prearrest CO after 15 min-
utes’ and 46%, 36%, and 13% at 60 minutes’ reperfusion,
respectively (Figure 3, A, and Table 2). Similar recovery pro-
files were found with SV (Figure 3, B). After 2 hours’ arrest,
the AL 5.9 mmol/L Kþgroup recovered 0.22  0.1 mL/beat
(84% of prearrest SV) and 0.24  0.1 mL/beat (90% recov-
ery was achieved at 15 minutes). This recovery was signifi-
cantly higher than that seen in the AL 3 mmol/L Kþ, AL 16
mmol/L Kþ, and 16 mmol/L Kþ alone groups.gery c June 2010
Sloots and Dobson Evolving Technology/Basic ScienceDISCUSSION
Surgeons have known for decades that depolarizing cardi-
oplegia does not afford optimal cardioprotection.2,3 A num-
ber of years ago, we introduced an alternative arrest,
protection, and preservation concept using nondepolarizing
normokalemic AL.7,8,12 The aim of the present study was to
examine the effects of varying the concentration of extracel-
lular Kþ in AL cardioplegia on arrest and reanimation prop-
erties in the isolated working rat heart at warm temperatures.
We show that warm AL cardioplegia is most efficient under
normokalemic conditions when the myocardial cell mem-
brane potential is close to its resting state. Hearts arrested
with lower Kþconcentrations (hyperpolarizing cardioplegia)
or higher Kþ concentrations (depolarizing cardioplegia) had
significantly higher CVRs during arrest, experienced reani-
mation arrhythmias, and were slow to recover, with signifi-
cant losses in CO, SV, and contractility. Nearly 40% of
hearts in the AL 0.1 mmol/L Kþ and 25 mmol/L Kþ alone
groups failed to return HR, developed pressures, or CO after
1 hour’s arrest.E
T
/B
SEffect of Changing Extracellular KþConcentrations
on Cardiac Membrane Potential
The theoretic relationship between resting membrane po-
tential and transmembrane Kþ concentration gradient was
first proposed in 1902 by German physiologist Julius Bern-
stein,18 after Ostwald and Nernst. We report a Nernstian re-
lationship between changing Kþ concentrations and
membrane potential (4) in the arrested heart: 4 (mV) ¼
26.23 ln [Kþ mmol/L]  123.44 (R2 ¼ 0.99; Figure 1, A).
This finding is in good agreement with our previous work
on the rat heart12,19 and with the large number of indepen-
dent microelectrode measurements made on in vivo, isolated
heart and myocyte preparations.4,20,21 For example, Snabai-
tis and colleagues4 measured50 mV in the isolated rat heart
perfused with 16 mmol/L Kþ alone in K–H buffer (n ¼ 8),
and Kleber20 measured82  2 mV in the isolated guinea
pig heart perfused with 4.5 mmol/L Kþ (n ¼ 6). From Fig-
ure 1, A, our values for Snabaitis and colleagues’4 and Kleb-
er’s20 measurements are50.7 and84 mV, respectively, at
identical Kþ concentrations. Similarly, at lower Kþ concen-
trations (3.0 mmol/L), Wan and coworkers21 measured
93 mV using microelectrodes in ventricular myocytes of
guinea pigs, and our value from Figure 1, A, is 94 mV
and in good agreement given the limitations of both
methods. In the present study we did not estimate the mem-
brane potential throughout the arrest period but only at in-
duction. Snabaitis and colleagues4 showed that membrane
potential remained relatively constant during polarized and
nonpolarized arrest time in the rat heart receiving tetrodo-
toxin and 16 mmol/L K solution, respectively. It would be
of interest to conduct future studies with both microelectrode
measurements and Nernstian Kþ distributions during arrestThe Journal of Thoracic and Carinduction, maintenance, and recovery. Because the Nernst
equation strictly describes an equilibrium state, our data
lend support to the concept that the resting membrane poten-
tial in the heart is not a diffusion potential but arises from
a measure of electrical work.6,22 Our data indicate that the
net myocardial transmembrane flux of Kþ over the range
of 0.1 to 25 mmol/L Kþis zero, which means during diastolic
arrest, the net inward current (eg, sum of rectifier IK1)23 is
equal to the net reversal potential for Kþ ions whereOG0
[Kþ]o/i ¼ 0.19,22 In conclusion, despite decreasing the trans-
membrane gradient by increasing extracellular Kþ concen-
trations from 5.9 to 25 mmol/L (increasing depolarization),
as is widely used to induce arrest in cardiac surgery, our
study indicates that the heart membrane potential follows
a Nernstian relationship.
Effect of Changing Kþ and Membrane Potential on
CVR During Arrest
Hypokalemia. We showed that hypokalemic AL arrest
(0.1 and 3.0 mmol/L Kþ) led to significantly higher CVR
values (up to 2.6-fold after 2 hours’ arrest) compared with
AL normokalemia (Figure 1, B). In 1974, Brace and associ-
ates24 reported that an intracoronary hypokalemic (2.1
mmol/L Kþ) infusion into the canine heart in vivo under con-
stant pressure led to reduced blood flow and increased oxy-
gen consumption. They concluded that the increase in CVR
was either the result of active vasoconstriction (direct vascu-
lar smooth muscle contraction), passive vasoconstriction
(extravascular compression), or both.
Normokalemia. The CVR for AL cardioplegia with 5.9
mmol/L Kþ increased by only 30% over 2 hours’ warm ar-
rest (0.24 to 0.31  0.01 megadyne $ s1 $ cm5, n ¼ 16).
Brace and associates24 reported that a small Kþwindow ex-
ists between approximately 5 and 10 mmol/L at which re-
duced CVR and dilation occurs; however, we did not
investigate this window in the present study.
Hyperkalemia. For many decades, hyperkalemia has
been linked to increased CVR, endothelial dysfunction,
and vasospasm.9,25,26 We confirmed our earlier results in
the isolated rat heart showing that hyperkalemia increases
CVR during warm arrest8,12 and that CVR was linearly re-
lated to extracellular Kþ in AL cardioplegia (from 5.9 to 16
mmol/L; Figure 1, B, insert). It is noteworthy that the rate
of change in CVR with increasing Kþ (slope) was more
than 2 times higher with doubling of arrest time (Table
1 and Figure 1, B, insert). In terms of membrane potential,
hyperpolarization (183 and 94 mV) or depolarization
(65, 49, and 39 mV) increases CVR to a significantly
greater extent than does normokalemic AL membrane po-
larization (Figure 1, C). We conclude that diastolic arrest
voltages outside the normal physiologic limits have an un-
toward effect on CVR and might reduce cardioplegia dis-
tribution and compromise protection during surgical arrest
and reanimation.diovascular Surgery c Volume 139, Number 6 1583
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Arrhythmias
Time to first spontaneous ventricular beat also increased
linearly with extracellular Kþ concentrations in AL cardio-
plegia (Figure 2, A and C). After 1 hour, time to first beat
increased from 2.3 to 5.5 minutes, and after 2 hours, it in-
creased from 2.5 to 12 minutes (Figure 2, A and C). Inter-
estingly, the difference in slopes in Figure 2, C, shows that
time to first spontaneous ventricular beat (in minutes) per
millimole per liter of Kþ is 3 times longer after 2 hours’
arrest and importantly that time to first spontaneous ven-
tricular beat for AL (5.9 mmol/L Kþ) was unchanged (Fig-
ure 2, C). Similar relations were found for time to first AF
(Figure 2, B and D). Increasing Kþ concentrations also in-
creased the incidence of abnormal heart rhythms during re-
animation. Hearts arrested with AL 5.9 mmol/L Kþ
cardioplegia for 1 and 2 hours’ arrest were the only groups
in which all hearts showed continual and consistent spon-
taneous beating with no arrhythmias in early reperfusion
(Data not shown).
Recovery of Pump Function
Hearts arrested with nornokalemic AL (5.9 mmol/L Kþ)
cardioplegia were also superior in functional recovery of
HR, developed pressures, AF, CF, CO, and SV compared
with those hearts receiving hypokalemic or hyperkalemic
AL cardioplegia or 16 and 25 mmol/L Kþalone cardioplegia
(Table 2 and Figure 3).
We found that after 1 and 2 hours’ warm arrest, the AL 5.9
mmol/L Kþ cardioplegia groups recovered rapidly and pre-
dictably 90% to 110% of HR, developed pressures, AF,
CF, and CO (Table 2 and Figure 3, A). After 2 hours, hearts
receiving depolarizing AL 10 mmol/L Kþ cardioplegia re-
covered function slower, with significantly lower CO at 15
minutes’ reperfusion (Table 2 and Figure 3, A). Increasing
the Kþ concentration to 16 mmol/L in AL cardioplegia led
to further functional loss in recovery of HR, developed pres-
sures, AF, CF, and CO (Table 2 and Figure 3, A). Interest-
ingly, nearly all metrics changed in a linear fashion with
increasing Kþ concentrations (from 5.9 to 16 mmol/L) at
15 and 60 minutes’ reperfusion (Table 2 and Figure 3). Fur-
thermore, doubling the arrest time exacerbated the damaging
effects of Kþ (see the Results section). The lower functional
recoveries for the AL 10 and 16 mmol/L Kþ or 16 and 25
mmol/L Kþ alone groups might be due to Kþ-induced myo-
cardial (and vascular) stunning through Hþ ion imbalances,
oxidative stress, calcium overload, and mitochondrial oxida-
tive dysfunction.11
The effect of increasing Kþ concentrations in AL cardio-
plegia on loss of functional recovery was highlighted by a de-
crease of up to 67% in SV (Figure 3, B). SV (in milliliters
per beat) was calculated by dividing CO by HR, and because
the preload (10 cm H2O) and afterload (100 cm H2O) are
preset in the working heart preparation, a decrease in SV1584 The Journal of Thoracic and Cardiovascular Surmight indicate a decrease in left ventricular contractility.
The relationship between SV and increasing Kþ concentra-
tions in the AL cardioplegia after 1 hour’s arrest at 15 min-
utes’ reperfusion was as follows: SV (mL/beat) ¼0.0085
[Kþ mmol/L]þ0.2771 (R2 ¼ 0.84). That after 2 hours was
as follows: SV (mL/beat) ¼ 0.0152 [Kþ mmol/L] þ
0.3103 (R2 ¼ 0.88). After 2 hours, SV decreased by up to
67% at 15 minutes’ and 60% at 60 minutes’ reperfusion,
and the rate of decrease was more than 10-fold compared
with that seen in the 1-hour arrest group at 60 minutes’ reper-
fusion (Figure 3, B and C). We conclude that increasing Kþ
concentrations from 5.9 to 10 and 16 mmol/L in AL cardio-
plegia results in a significant loss of CO, SV, and left ventric-
ular contractility, and the decrease is more pronounced the
longer the arrest time. Pressure–volume loops or an intra-
ventricular balloon would be required to quantify the effects
of AL with varying Kþconcentrations on changes in contrac-
tility (eg, degree of sarcomere stretch) during recovery. In
cell voltage terms the more the cardiomyocyte, heart con-
duction cells, and cells of the coronary vasculature appear
to deviate from their natural resting membrane potentials
during cardioplegic arrest, the greater the loss of cardiac
function during arrest, reanimation, and reperfusion.
Possible Clinical Significance: Polarized Versus
Depolarized Cardioplegia
Although the underlying mechanisms of AL likely involve
an interaction of adenosine receptors, Naþfast channels, pro-
tein kinase C survival pathways, and adenosine triphos-
phate–sensitive Kþ channels (mitochondrial and
sarcolemmal),12 the key to polarized arrest and related polar-
izing cardioprotection strategies is that there are fewer volt-
age-dependent membrane channels, pores, and exchangers
(Naþ/Hþ and Naþ/Ca2þ) open compared with depolarized
states.5,12 Depolarizing Kþ cardioplegia has been a double-
edged sword in cardiac surgery for more than 4 decades,
particularly after Tyers and colleagues27 demonstrated
unequivocally that Kþ, and not citrate, was responsible for
the clinical failure of Melrose’s method. Currently, there
are at least 5 clinical concerns with depolarizing Kþ cardio-
plegia. These include (1) generating unnatural voltages and
ionic gradients in the heart leading to cell Naþand Ca2þ load-
ing,11 which are exacerbated with longer crossclamp
times7,12; (2) coronary vasoconstriction leading to higher
resistances, suboptimal delivery pressure–flow relations,
and nonuniform distribution of cardioplegia28,29; (3) damage
to the vascular endothelium and smooth muscle interactions,
which predispose the coronary vessels to spasm9,30; (4) the
occurrence of postoperative atrial and ventricular arrhyth-
mias, including conduction disturbances10; and (5) ventricu-
lar dysfunction, such as postcardioplegia stunning.11
Because polarizing normokalemic AL cardioplegia main-
tains cell voltages close to resting values, this strategy might
offer surgeons an alternative and address the growinggery c June 2010
Sloots and Dobson Evolving Technology/Basic Scienceconcern about the lack of cardioprotection in high-risk pa-
tients undergoing cardiac surgery or those with extended
crossclamp times. Although the present study was con-
ducted on healthy hearts, future studies need to be conducted
on older hearts with comorbidities and neonatal hearts. A
few clinical data are available on crystalloid and all-blood
AL cardioplegia in pediatric and adult cardiac surgery. Jin
and associates31 reported that a ‘‘one shot’’ of AL 10
mmol/L Kþ crystalloid cardioplegia was more protective
than AL 20 mmol/L Kþor non-AL 20 mmol/L Kþcardiople-
gia alone in 134 pediatric patients undergoing correction of
ventricular septal defect. With decreasing Kþconcentrations,
these authors showed that as the membrane potential shifted
toward more polarized levels (ie, from46 to67 mV), there
was (1) a reduced use of inotropes, (2) a significantly lower
release of troponin I after surgical intervention, and (3) 1 day
less of hospitalization.31 Our data in the present study help to
explain some of the advantages of physiologic levels of Kþin
AL cardioplegia.
Another clinical case study using all-blood AL (or Adeno-
caine; Hibernation Therapeutics, Wulguru, Australia) cardi-
oplegia was reported for a 43 redo high-risk patient with
infective endocarditis requiring mitral and aortic value re-
placements with aortic root enlargement. During cardiopul-
monary bypass (9.8 hours, with a total arrest time of 7
hours), the patient’s heart was kept quiescent with 72 L of
all-blood Adenocaine microplegia (with 2 mmol/L Kþ) for
nearly 5 hours. The patient required no balloon pump and
a low level of inotropic support, was extubated in 12 hours,
and was transferred from the intensive care unit after 48
hours with a subsequent uneventful recovery.32 Another
possible advantage for normokalemic AL cardioplegia
would be in patients with renal disease or those receiving di-
alysis who cannot tolerate fluctuations in plasma Kþconcen-
trations.
We thank Donna Rudd and Professor Jakob Vinten–Johansen
for comments on the manuscript.E
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Appendix 1
Estimation of Myocardial Membrane Potential
Left ventricular tissue of prearrest and arrested hearts at
induction was freeze-clamped at liquid N2 temperatures,
ground in a mortar, and stored at80C until used. Samples
of tissue (50–100 mg) were digested with nitric acid and
analyzed for total tissue Kþ concentrations (mg/kg) with
a Varian Liberty Series II Inductively Coupled Plasma
Atomic Emission Spectrometer (Melbourne, Australia).
Membrane potential (VM or 4 in mV) was calculated from
the Nernstian distribution of Kþion between the extracellular
and intracellular phases (equation 1).
VM ¼ EKþ ¼ RT
ZKþF
3 ln
½KþOUT
½KþIN
(1)
where R is the universal gas constant (8.31 J mol1 K1), F is
Faraday’s constant (96.49 KJ mol1 V1), T is absolute
temperature (305.15 K), z is the valence of Kþ ion (þ1),
and [Kþ]IN and [K
þ]OUT are the intracellular and extracellular
concentrations of the Kþ ion in moles per liter, respec-
tively.12 The [Kþ]IN was calculated from the following
equation: [Kþ]TOTAL ¼ x [Kþ]IN þ y [Kþ]OUT, where x is
the intracellular space and y is the extracellular space,
respectively. In the perfused working rat heart, the
distribution of total tissue water is 41% intracellular and
59% extracellular.19 It was assumed that [Kþ]OUT was equal
to the Kþconcentrations in the various cardioplegic solutions
(0.1, 3.0, 5.9, 10, 16, or 25 mmol/L Kþ). Total tissue water
was measured and calculated from the difference between
wet and dry weight, divided by wet weight, and multiplied
by 100.19
Coronary Vascular Resistance
CVR (megadyne $ s1 $ cm5) was calculated by dividing
delivery pressure (mm Hg) by flow (volume/s) from equa-
tion 2 as follows:
CVR ¼ 13333mm HgðmL=sÞ 3 10
6 (2)
where 1 mm Hg ¼ 1333 dynes $ cm2, and 106 is
a conversion factor from dynes to megadynes.12
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